Madrigal Pharmaceuticals, Inc. 0JXI.L Stock
Madrigal Pharmaceuticals, Inc. Price Chart
Madrigal Pharmaceuticals, Inc. 0JXI.L Financial and Trading Overview
| Madrigal Pharmaceuticals, Inc. stock price | 241.69 USD |
| Previous Close | 257.26 USD |
| Open | 0 USD |
| Bid | 0 USD x 0 |
| Ask | 0 USD x 0 |
| Day's Range | 0 - 0 USD |
| 52 Week Range | 0 - 313 USD |
| Volume | 195 USD |
| Avg. Volume | 303 USD |
| Market Cap | 38.94M USD |
| Beta (5Y Monthly) | -0.705281 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -14.647 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
0JXI.L Valuation Measures
| Enterprise Value | 4.46B USD |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | 30.819532 |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | -14.212 |
Trading Information
Madrigal Pharmaceuticals, Inc. Stock Price History
| Beta (5Y Monthly) | -0.705281 |
| 52-Week Change | 238.89% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 313 USD |
| 52 Week Low | 0 USD |
| 50-Day Moving Average | 272.36 USD |
| 200-Day Moving Average | 244.86 USD |
0JXI.L Share Statistics
| Avg. Volume (3 month) | 303 USD |
| Avg. Daily Volume (10-Days) | 48 USD |
| Shares Outstanding | 15.39M |
| Float | 10.35M |
| Short Ratio | N/A |
| % Held by Insiders | 17.67% |
| % Held by Institutions | 85.41% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | N/A |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -70.77% |
| Return on Equity (ttm) | -212.74% |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | -313836000 USD |
| Net Income Avi to Common (ttm) | -314728000 USD |
| Diluted EPS (ttm) | -14.647 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 329.48M USD |
| Total Cash Per Share (mrq) | 18.02 USD |
| Total Debt (mrq) | 84.62M USD |
| Total Debt/Equity (mrq) | 56.36 USD |
| Current Ratio (mrq) | 3.368 |
| Book Value Per Share (mrq) | 8.212 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -259011008 USD |
| Levered Free Cash Flow (ttm) | -142592496 USD |
Profile of Madrigal Pharmaceuticals, Inc.
| Country | United Kingdom |
| State | PA |
| City | West Conshohocken |
| Address | Four Tower Bridge |
| ZIP | 19428 |
| Phone | 267 824 2827 |
| Website | https://www.madrigalpharma.com |
| Industry | |
| Sector(s) | |
| Full Time Employees | 92 |
Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutics for the treatment of non-alcoholic steatohepatitis (NASH) in the United States. Its lead product candidate is resmetirom, a liver-directed selective thyroid hormone receptor beta agonist, which is in Phase III clinical trials for treating NASH. The company is also developing MGL-3745, a backup compound to resmetirom. The company is headquartered in West Conshohocken, Pennsylvania.
Q&A For Madrigal Pharmaceuticals, Inc. Stock
What is a current 0JXI.L stock price?
Madrigal Pharmaceuticals, Inc. 0JXI.L stock price today per share is 241.69 USD.
How to purchase Madrigal Pharmaceuticals, Inc. stock?
You can buy 0JXI.L shares on the LSE exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Madrigal Pharmaceuticals, Inc.?
The stock symbol or ticker of Madrigal Pharmaceuticals, Inc. is 0JXI.L.
How many shares does Madrigal Pharmaceuticals, Inc. have in circulation?
The max supply of Madrigal Pharmaceuticals, Inc. shares is 153.86K.
What is Madrigal Pharmaceuticals, Inc. Price to Earnings Ratio (PE Ratio)?
Madrigal Pharmaceuticals, Inc. PE Ratio is now.
What was Madrigal Pharmaceuticals, Inc. earnings per share over the trailing 12 months (TTM)?
Madrigal Pharmaceuticals, Inc. EPS is -14.647 USD over the trailing 12 months.